Curis Inc. Common Stock (CRIS)
Stock · NASDAQ · Health Care
$1.49as of 8/28/2026
Price chart
Open in TradingViewActive signals
About CRIS
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipelin…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 20
- Website
- www.curis.com/
Fundamentals
- 1-day range
- $1.45$1.58
- Market cap
- $10.04M
- P/E (trailing)
- —
- P/E (forward)
- -0.25
- EPS (trailing)
- $-10.99
- Dividend yield
- —
- Beta
- 3.38
- Avg. volume
- 283.3K
- Dividend pay date
- May 30, 2018
How Curis Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Curis Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CRISCuris Inc. Common Stock$1.49▲ 2.76%Market cap $10.04MP/E —$1.4$39
- BCDABioCardia Inc. Common Stock$1.16▼ 0.85%Market cap $9.45MP/E —$0.75$2.29
- INTSIntensity Therapeutics Inc. Common stock$4.25▲ 0.95%Market cap $11.51MP/E —$3.51$43.5
- SNTISenti Biosciences Holdings Inc. Common Stock$0.377▼ 0.26%Market cap $11.53MP/E —$0.3305$2.88
- AIMAIM ImmunoTech Inc. Common Stock$0.2558▲ 2.32%Market cap $7.32MP/E —$0.1901$2.89
- PASGPassage Bio Inc. Common Stock$4.52▲ 4.39%Market cap $14.40MP/E —$3.29$20
- BCABBioAtla Inc. Common Stock$1.79▼ 42.99%Market cap $5.41MP/E —$2.81$71.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CRIS Curis Inc. Common Stock | $10.04M | — | $1.49 | ▲ 2.76% | $1.4$39 |
| BCDA BioCardia Inc. Common Stock | $9.45M | — | $1.16 | ▼ 0.85% | $0.75$2.29 |
| INTS Intensity Therapeutics Inc. Common stock | $11.51M | — | $4.25 | ▲ 0.95% | $3.51$43.5 |
| SNTI Senti Biosciences Holdings Inc. Common Stock | $11.53M | — | $0.377 | ▼ 0.26% | $0.3305$2.88 |
| AIM AIM ImmunoTech Inc. Common Stock | $7.32M | — | $0.2558 | ▲ 2.32% | $0.1901$2.89 |
| PASG Passage Bio Inc. Common Stock | $14.40M | — | $4.52 | ▲ 4.39% | $3.29$20 |
| BCAB BioAtla Inc. Common Stock | $5.41M | — | $1.79 | ▼ 42.99% | $2.81$71.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 8/18/2026
- HC Wainwright & Co. Reiterates Buy on Curis, Maintains $43 Price TargetBenzinga · 8/17/2026
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 8/13/2026
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga · 8/12/2026
- What's going on in today's sessionChartMill · 8/11/2026
- Here are the top movers in Tuesday's session.ChartMill · 8/11/2026
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · 8/11/2026
- Curis (CRIS) Stock Fair Value Moves Lower After Emavusertib TakeAim Model ReworkYahoo · 8/5/2026
Insider Activity
Insider Actions →- Marc Rubin · July 7, 2026 · Grant6.8K @ $5.29
- Kenneth I. Kaitin · July 7, 2026 · Grant6.8K @ $5.29
- Hohneker John · July 7, 2026 · Grant6.8K @ $5.29
- GREENACRE MARTYN D · July 7, 2026 · Grant6.8K @ $5.29
- Borgman Anne Elizabeth · July 7, 2026 · Grant6.8K @ $5.29
- Diantha Duvall · July 7, 2026 · Grant48.3K @ $5.29
- Jonathan B. Zung · July 7, 2026 · Grant48.3K @ $5.29
- James E. Dentzer · July 7, 2026 · Grant110.1K @ $5.29
- Kenneth I. Kaitin · March 31, 2026 · Buy10.0K @ $0.5487
- Jonathan B. Zung · March 20, 2026 · Conversion50
- Jonathan B. Zung · March 20, 2026 · Conversion66.7K
- Ahmed Hamdy, MD · March 20, 2026 · Conversion50
- Ahmed Hamdy, MD · March 20, 2026 · Conversion66.7K
- Diantha Duvall · March 20, 2026 · Conversion50
- Diantha Duvall · March 20, 2026 · Conversion66.7K
See the full, filterable feed with live charts on the MarketWall dashboard.